12-14 May 2026, ASGBI Congress 2026; Brighton
The Association of Surgeons of Great Britain and Ireland (ASGBI) Annual Congress is a premier event for general surgeons, surgical...
Read MoreLorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
Surging spinal and joint disorders supporting orthobiologics demand
The global orthobiologics market was valued at approximately USD 6.8 billion in 2023 and is estimated to grow at a...
Read MoreOTWorld 2026: Anniversary campaign “50 years – 50 voices” gives patients worldwide a voice
To mark the 50th anniversary of OTWorld, the international campaign "50 years – 50 voices" is being launched. The focus...
Read MoreSix weeks in a cast no less effective than surgery for unstable ankle fractures
Cast also carries fewer treatment related harms than surgery, say researchers Wearing a cast for six weeks appears to be...
Read More19-22 May 2026, OTWorld Congress; Leipzig, Germany
Congress Programme 2026 – Your Knowledge Makes the Difference 2026 is a special year – we are celebrating 50 years...
Read MoreRising orthopaedic disorders driving demand for orthopaedic splints
The global orthopaedic splints market was valued at over USD 2.3 billion in 2022 and is projected to reach approximately...
Read MoreNew laser treatment may reduce the need for knee replacement surgery
Study introduces new laser device for treating knee osteoarthritis that may delay or replace the need for joint replacement surgery....
Read MoreNovadip recruits first pediatric patients in pivotal phase 3 trial of tissue regenerative treatment
Phase 3 trial in adult patients also planned for 2026 with focus on limb sparing associated with bone non-union (BNU)...
Read More